Evidence mapPaperPMID 39844705Full record

ArticleSe pu = Chinese journal of chromatography2025

[Determination of three metabolites of thromboxane A

Si-Jia Liu, Fu-Rong Zhao, Ya-Lian Zhang, Xiao-Yu Sun, Meng-Meng Zhang, Kun Hou, Yun-Feng Cao

Abstract readEnglish Abstract
In one paragraph

Article in Se pu = Chinese journal of chromatography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Si-Jia LiuSchool of Pharmacy, Jinzhou Medical University, Jinzhou 121001, China.
Fu-Rong ZhaoLiaoning Provincial Key Laboratory of Clinical Oncology Metabonomics, Jinzhou Medical University, Jinzhou 121001, China.
Ya-Lian ZhangDalian Boyuan Medical Technology Co. Ltd., Dalian 116011, China.
Xiao-Yu SunShanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai 200237, China.
Meng-Meng ZhangDalian Boyuan Medical Technology Co. Ltd., Dalian 116011, China.
Kun HouDalian Boyuan Medical Technology Co. Ltd., Dalian 116011, China.
Yun-Feng CaoShanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai 200237, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thromboxane A

Indexed as

DinoprostLiquid Chromatography-Mass SpectrometryThromboxane A2UrinalysisHumansIschemic StrokeLimit of Detection8-epi-prostaglandin F2alphaDinoprostThromboxane A211-dehydro-2,3-dinor thromboxane B11-dehydro thromboxane B2,3-dinor thromboxane B8-iso-prostaglandin Fischemic strokeultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS)urine

Identifiers

PMID39844705
PMCPMC11755747

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.